D-0020-2024 Class II Terminated
FDA drug recall D-0020-2024 was initiated by Central Admixture Pharmacy Services Inc on Sep 21, 2023 and is designated Class II. Reason for recall: Lack of assurance of sterility: The recall status is terminated (terminated Mar 19, 2025). Affected quantity: 174, 5 mL syringes..
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 11, 2023
- Initiation Date
- Sep 21, 2023
- Termination Date
- Mar 19, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 174, 5 mL syringes.
Product Description
fentaNYL, 250 mcg/5 mL, (50 mcg/mL), 5 mL Syringe, Rx only, Repackaged by CAPS Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-2
Reason for Recall
Lack of assurance of sterility:
Distribution Pattern
Nationwide in the USA
Code Information
Lot:17-275479, Exp. 10/4/2023; 17-275852, Exp. 10/11/2023